LU86405A1 - Derive antipsychotique du benzisothiazole s-oxyde - Google Patents

Derive antipsychotique du benzisothiazole s-oxyde Download PDF

Info

Publication number
LU86405A1
LU86405A1 LU86405A LU86405A LU86405A1 LU 86405 A1 LU86405 A1 LU 86405A1 LU 86405 A LU86405 A LU 86405A LU 86405 A LU86405 A LU 86405A LU 86405 A1 LU86405 A1 LU 86405A1
Authority
LU
Luxembourg
Prior art keywords
compound
bmy
pharmaceutically acceptable
acid
formula
Prior art date
Application number
LU86405A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU86405A1 publication Critical patent/LU86405A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU86405A 1985-04-24 1986-04-23 Derive antipsychotique du benzisothiazole s-oxyde LU86405A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72644985 1985-04-24
US06/726,449 US4656173A (en) 1985-04-24 1985-04-24 Antipsychotic benzisothiazole S-oxide compound

Publications (1)

Publication Number Publication Date
LU86405A1 true LU86405A1 (fr) 1986-11-05

Family

ID=24918649

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86405A LU86405A1 (fr) 1985-04-24 1986-04-23 Derive antipsychotique du benzisothiazole s-oxyde

Country Status (26)

Country Link
US (1) US4656173A (ko)
JP (1) JPH0764842B2 (ko)
KR (1) KR900000372B1 (ko)
CN (1) CN1017528B (ko)
AT (1) AT394719B (ko)
AU (1) AU592787B2 (ko)
BE (1) BE904662A (ko)
CA (1) CA1247102A (ko)
CH (1) CH666034A5 (ko)
DE (1) DE3613739C2 (ko)
DK (1) DK187686A (ko)
EG (1) EG18002A (ko)
ES (1) ES8708228A1 (ko)
FI (1) FI84604C (ko)
FR (1) FR2581064B1 (ko)
GB (1) GB2174393B (ko)
GR (1) GR861063B (ko)
HU (1) HU195654B (ko)
IE (1) IE59182B1 (ko)
IT (1) IT1208600B (ko)
LU (1) LU86405A1 (ko)
MY (1) MY102041A (ko)
NL (1) NL8601043A (ko)
PT (1) PT82450B (ko)
SE (1) SE462163B (ko)
ZA (1) ZA861531B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
HUT61760A (en) * 1988-09-16 1993-03-01 Pfizer Process for producing bridged, bicyclic imides comprising 4-/4-(3-benzisothiazolyl)-1-piperazinyl/-butyl group and pharmaceutical compositions comprising such compounds
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
CH582699A5 (ko) * 1973-03-26 1976-12-15 Sandoz Ag
AT342057B (de) * 1974-04-25 1978-03-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen 3-piperazino-isochinolinen und deren salzen
FI753625A (ko) * 1975-01-06 1976-07-07 Spofa Vereinigte Pharma Werke
JPS51144735A (en) * 1975-06-06 1976-12-13 Nippon Nohyaku Co Ltd A remedy for hepatic failure
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Also Published As

Publication number Publication date
FR2581064A1 (fr) 1986-10-31
DE3613739C2 (de) 1993-12-09
JPS61251683A (ja) 1986-11-08
HU195654B (en) 1988-06-28
CN86102742A (zh) 1987-02-04
PT82450A (en) 1986-05-01
AT394719B (de) 1992-06-10
CH666034A5 (de) 1988-06-30
IT8620187A0 (it) 1986-04-23
BE904662A (fr) 1986-10-23
DE3613739A1 (de) 1986-11-20
FI861668A0 (fi) 1986-04-21
FI861668A (fi) 1986-10-25
SE462163B (sv) 1990-05-14
FI84604C (fi) 1991-12-27
FI84604B (fi) 1991-09-13
CN1017528B (zh) 1992-07-22
SE8601883L (sv) 1986-10-25
AU592787B2 (en) 1990-01-25
GR861063B (en) 1986-09-01
PT82450B (pt) 1988-11-30
CA1247102A (en) 1988-12-20
MY102041A (en) 1992-02-29
ES8708228A1 (es) 1987-10-01
HUT42088A (en) 1987-06-29
FR2581064B1 (fr) 1988-09-16
ATA110486A (de) 1991-11-15
KR900000372B1 (ko) 1990-01-25
DK187686D0 (da) 1986-04-23
IT1208600B (it) 1989-07-10
NL8601043A (nl) 1986-11-17
IE861083L (en) 1986-10-24
GB2174393B (en) 1989-02-01
AU5612186A (en) 1986-10-30
US4656173A (en) 1987-04-07
GB8609932D0 (en) 1986-05-29
IE59182B1 (en) 1994-01-26
DK187686A (da) 1986-10-25
GB2174393A (en) 1986-11-05
ZA861531B (en) 1986-10-29
EG18002A (en) 1991-08-30
JPH0764842B2 (ja) 1995-07-12
KR860008174A (ko) 1986-11-12
ES554284A0 (es) 1987-10-01
SE8601883D0 (sv) 1986-04-23

Similar Documents

Publication Publication Date Title
EP0497659B1 (fr) Dérivés d'aryl (ou hétéroaryl)-piperaz inyl-alkyl-azoles, leur préparation et leur application en tant que médicaments
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP1309594B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
EP0850235B1 (fr) Derives de quinolein-2(1h)-one comme antagonistes de la serotonine
EP0501892B1 (fr) Dérivés hétérocycliques diazotés N-substitués par un groupement biphénylméthyle, leur préparation, les compositions pharmaceutiques en contenant
LU84011A1 (fr) 2-phenoxyalkyl-1,2,4-triazol-3-ones antidepressives
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
EP0557171A1 (fr) Azaindoles, procédés de préparation et médicaments les contenant
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
EP0429341A2 (fr) Dérivés hétérocycliques, leur préparation et les médicaments les contenant
LU85561A1 (fr) 1,2,4-triazol-3-ones,antidepressives
EP1966173B1 (fr) Derives heterocycliques, leur preparation et leur application en therapeutique.
EP0623138B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
EP0429360A2 (fr) Inhibition du syndrome d'abstinence
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2584408A1 (fr) Derives diazinylpiperidiniques d'amines et d'imides cycliques a application psychogeriatrique
EP0385848A1 (fr) Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
FR2753970A1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
CH661271A5 (fr) Derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
WO1991016323A1 (fr) Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant
CA2346506C (fr) Derives d'aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone comme agonistes du recepteur 5-ht1
CA1263862A (fr) Derives d'amino-5 pentanenitrile et leur procede de preparation
FR2522663A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments